1. Home
  2. ALKS vs BDC Comparison

ALKS vs BDC Comparison

Compare ALKS & BDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALKS
  • BDC
  • Stock Information
  • Founded
  • ALKS 1987
  • BDC 1902
  • Country
  • ALKS Ireland
  • BDC United States
  • Employees
  • ALKS N/A
  • BDC N/A
  • Industry
  • ALKS Biotechnology: Pharmaceutical Preparations
  • BDC Telecommunications Equipment
  • Sector
  • ALKS Health Care
  • BDC Telecommunications
  • Exchange
  • ALKS Nasdaq
  • BDC Nasdaq
  • Market Cap
  • ALKS 4.9B
  • BDC 5.2B
  • IPO Year
  • ALKS 1991
  • BDC 1993
  • Fundamental
  • Price
  • ALKS $30.82
  • BDC $115.12
  • Analyst Decision
  • ALKS Strong Buy
  • BDC Strong Buy
  • Analyst Count
  • ALKS 14
  • BDC 5
  • Target Price
  • ALKS $41.43
  • BDC $135.20
  • AVG Volume (30 Days)
  • ALKS 1.9M
  • BDC 255.6K
  • Earning Date
  • ALKS 10-23-2025
  • BDC 10-30-2025
  • Dividend Yield
  • ALKS N/A
  • BDC 0.17%
  • EPS Growth
  • ALKS 21.99
  • BDC 16.75
  • EPS
  • ALKS 2.08
  • BDC 5.50
  • Revenue
  • ALKS $1,505,296,000.00
  • BDC $2,617,821,000.00
  • Revenue This Year
  • ALKS N/A
  • BDC $9.55
  • Revenue Next Year
  • ALKS $1.59
  • BDC $5.01
  • P/E Ratio
  • ALKS $14.89
  • BDC $20.86
  • Revenue Growth
  • ALKS N/A
  • BDC 12.93
  • 52 Week Low
  • ALKS $25.17
  • BDC $83.18
  • 52 Week High
  • ALKS $36.45
  • BDC $133.77
  • Technical
  • Relative Strength Index (RSI)
  • ALKS 62.83
  • BDC 31.32
  • Support Level
  • ALKS $26.99
  • BDC $116.70
  • Resistance Level
  • ALKS $31.68
  • BDC $119.75
  • Average True Range (ATR)
  • ALKS 0.80
  • BDC 2.99
  • MACD
  • ALKS 0.36
  • BDC -1.55
  • Stochastic Oscillator
  • ALKS 81.88
  • BDC 0.78

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

About BDC Belden Inc

Belden designs, manufactures, and markets advanced networking, connectivity, and cable solutions for industrial automation, smart buildings, and broadcast markets. Their portfolio includes cables, connectors, and networking equipment, enabling secure, reliable data transmission for applications in data centers, healthcare, education, hospitality, and more.

Share on Social Networks: